PP
PFE icon

Prospector Partners’s Pfizer PFE Stock Holding History

Prospector Partners’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-97,307
Closed -$2.48M – 63
2025
Q3 		$2.48M Sell
97,307
-22,574
-19% -$557K 0.3% 72
2025
Q2 		$2.91M Sell
119,881
-22,574
-16% -$526K 0.33% 72
2025
Q1 		$3.61M Buy
142,455
+53,900
+61% +$1.41M 0.41% 69
2024
Q4 		$2.35M Buy
88,555
+6,800
+8% +$184K 0.26% 74
2024
Q3 		$2.37M Hold
81,755
– – 0.25% 75
2024
Q2 		$2.29M Hold
81,755
– – 0.26% 75
2024
Q1 		$2.27M Hold
81,755
– – 0.25% 77
2023
Q4 		$2.35M Sell
81,755
-325,460
-80% -$9.84M 0.29% 73
2023
Q3 		$13.5M Buy
407,215
+120,410
+42% +$4.26M 1.82% 15
2023
Q2 		$10.5M Buy
286,805
+10,975
+4% +$427K 1.47% 29
2023
Q1 		$11.3M Buy
275,830
+71,730
+35% +$3.1M 1.57% 24
2022
Q4 		$10.5M Buy
204,100
+59,025
+41% +$2.83M 1.43% 25
2022
Q3 		$6.35M Buy
145,075
+825
+0.6% +$40.1K 0.95% 43
2022
Q2 		$7.56M Buy
144,250
+1,950
+1% +$99.4K 1.1% 37
2022
Q1 		$7.37M Sell
142,300
-18,950
-12% -$983K 0.91% 46
2021
Q4 		$9.52M Buy
161,250
+54,650
+51% +$2.71M 1.1% 40
2021
Q3 		$4.58M Buy
+106,600
New +$4.72M 0.59% 60
2014
Q4 		– Sell
-183,080
Closed -$5.14M – 174
2014
Q3 		$5.14M Sell
183,080
-68,510
-27% -$1.92M 0.28% 99
2014
Q2 		$7.08M Sell
251,590
-11,594
-4% -$330K 0.34% 94
2014
Q1 		$8.02M Sell
263,184
-762,479
-74% -$22.7M 0.38% 89
2013
Q4 		$29.8M Sell
1,025,663
-947,177
-48% -$27.6M 1.33% 20
2013
Q3 		$53.7M Sell
1,972,840
-94,228
-5% -$2.56M 2.44% 3
2013
Q2 		$54.9M Buy
+2,067,068
New +$57.1M 2.71% 4

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Prospector Partners's PFE Position: Q4 2025 in Review

Prospector Partners sold out of Pfizer (PFE) in Q4 2025, closing a stake of 97,307 shares — an estimated $2.48M sold.

Prospector Partners first reported a position in PFE in Q2 2013 and held it in 23 quarters. The position peaked at $54.9M in Q2 2013. 2,914 funds tracked by Wall St. Rank hold PFE as of Q4 2025.

  • Prospector Partners reported no remaining Pfizer position as of Q4 2025 after selling out during the quarter.
  • Prospector Partners sold 97,307 Pfizer shares in Q4 2025, an estimated $2.48M.
  • Prospector Partners first reported a position in Pfizer in Q2 2013 and held it in 23 quarters.
  • Prospector Partners's Pfizer position peaked at $54.9M in Q2 2013.
  • 2,914 funds tracked by Wall St. Rank held Pfizer as of Q4 2025.

Based on Prospector Partners's 13F filing for Q4 2025, filed 13 Feb 2026.